AI Prior Authorization Vendors: Infinitus vs SuperDial vs Neon Health vs Coral AI | Rx Almanac
Head-to-head comparison of four AI-native prior authorization automation vendors targeting different segments of the pharma patient access workflow. Represents the emerging question of where AI ins...
Overview
Prior authorization is one of the most expensive administrative burdens in U.S. healthcare. Physicians spend an average of 13 hours per week on PA work per provider, and more than 94% say PA negatively impacts clinical outcomes. Total drug PA costs are estimated at $93.3 billion per year when accounting for costs absorbed by manufacturers, physicians, and patients.
AI PA spending grew roughly 10x year-over-year, from approximately $10 million in 2024 to $100 million in 2025. The global AI-powered PA market was sized at $1.42 billion in 2024 and is projected to reach $7.12 billion by 2033 at an 18.7% CAGR. Regulatory tailwinds are compounding demand: the CMS Interoperability and Prior Authorization Final Rule sets 2026 compliance deadlines mandating electronic PA APIs with 72-hour urgent and 7-day standard turnaround times.
Within this landscape, four vendors have emerged as distinctive competitors in the AI-native PA automation space: Infinitus Systems, SuperDial, Neon Health, and Coral AI. They reflect fundamentally different architectural bets, market hypotheses, and customer profiles.
Competitor Profiles
Infinitus Systems
Founded in 2019, headquartered in San Francisco. Built the first AI platform specifically designed to automate manual healthcare phone calls. Core insight: the payer system runs primarily on voice (an estimated 3.2 billion healthcare phone calls annually). For pharma, Infinitus focuses on call-intensive hub workflows: benefit verification, PA follow-up, PBM discovery, and formulary exception requests. Eight of the top 10 pharma companies trust Infinitus. Total funding: $102.9M (Series C), led by a16z, Kleiner Perkins, GV/Google Ventures, and Coatue.
SuperDial
Founded late 2023, headquartered in San Francisco. Builds AI agents that make outbound phone calls from providers and billing companies to insurers. Raised $15 million Series A in June 2025 led by SignalFire (total funding $20M+). Acquired voice AI specialist MajorBoost for call-tree navigation. Customer base is primarily RCM companies, dental service organizations, and large provider organizations — not pharma manufacturers or hub services.
Neon Health
Founded in San Francisco, raised a $6 million seed round in September 2025 led by NFX. Positioning is explicitly around specialty drug access for pharma manufacturers. Works with approximately six pharmaceutical brands and has landed CareMetx as a design partner and reference customer. Published case study: 300% ROI within three months, doubled BV throughput, 70% reduction in per-BV labor cost. Differentiation is multi-channel, end-to-end workflow orchestration purpose-built for the specialty Rx journey.
Coral AI
Founded in New York in 2024. Attacks the front-end of the patient access workflow: document intake, eligibility verification, and PA preparation. Seed round led by Lightspeed Venture Partners with participation from leaders at OpenAI and Zapier. Custom-trained models on real healthcare documents capable of reading handwriting, flipped insurance cards, and unstructured text. Processes over 500,000 patient workflows per month across DME providers, infusion centers, and specialty clinics. Customer base is provider-side, not pharma.
Head-to-Head Comparison
At a Glance
| Dimension | Infinitus | SuperDial | Neon Health | Coral AI |
|---|---|---|---|---|
| Founded | 2019 | 2023 | 2024 | 2024 |
| Total Funding | $102.9M | $20M+ | $6M | Seed (Lightspeed) |
| Stage | Series C | Series A | Seed | Seed |
| Primary tech | Voice AI (payer calls) | Voice AI (payer calls) | Multi-channel AI workers | Document AI + agentic workflows |
| Primary customer | Pharma / Hub services | RCM / Providers | Pharma / Hub services | Providers (DME, infusion, clinic) |
| PA workflow stage | Post-submission follow-up | Post-submission follow-up | End-to-end (BV through PA through fin. assist.) | Pre-submission (intake, prep, drafting) |
Technology Architecture
| Dimension | Infinitus | SuperDial | Neon Health | Coral AI |
|---|---|---|---|---|
| Core approach | Proprietary multimodal AI platform with discrete action space and knowledge graph | Voice AI agents + human call center fallback | Modular AI workforce: voice, web portal, SMS/fax/email, rules engine | Document AI (CV + ML) for unstructured data; agentic workflow automation |
| Hallucination control | Discrete action space limits LLM to approved response set; guardrails at every layer | Human-in-the-loop escalation | Rules Engine with 100% SOP scoring; human-in-the-loop exceptions | Custom-trained models on real docs; humans review/submit; 98.7% accuracy |
| Payer interaction | Voice AI calls payer, navigates IVR, multi-turn conversation | Voice AI calls payer, navigates IVR, talks to rep | Voice + portal navigation + fax (multi-channel) | Primarily portal/document-based |
| Key claim | 30% faster calls, 10% higher quality than humans (Cencora) | 3x cost savings per call, 4x productivity gains | 98%+ workflows automated, 300% ROI in 3 months (CareMetx) | 98.7% doc accuracy, 85% PA obtainment rate, 90% workload reduction |
| Compliance | HIPAA, SOC 2 Type 2, HITRUST Certified Cloud | HIPAA, SOC 2 Type 2 | HIPAA compliant | HIPAA, payer compliance |
Maturity and Scale
| Dimension | Infinitus | SuperDial | Neon Health | Coral AI |
|---|---|---|---|---|
| Years in market | ~6 | ~2 | ~1 | ~1 |
| Volume | 100M+ minutes of healthcare conversations; 4M+ calls in knowledge graph | Tens of thousands of calls per week | Not disclosed | 500K+ patient workflows/month |
| Payer coverage | 1,400+ payers; 1,000+ therapies | Not specified | Not specified | Not primarily payer-call-based |
| Pharma customers | 8 of top 10 pharma | Not disclosed (primarily providers, RCM) | ~6 pharma brands | Not disclosed |
| Hub services customers | Yes (Amgen SupportPlus, multiple hub partners) | No known hub relationships | CareMetx (design partner / reference) | No known hub relationships |
Integration Model
| Dimension | Infinitus | SuperDial | Neon Health | Coral AI |
|---|---|---|---|---|
| Hub/PSP role | Augments hub — automates payer call tasks | Not designed for hub services | Augments hub — purpose-built to embed in hub workflows | Does not target hub services |
| Deployment | API or Infinitus Portal; FastTrack copilot starts without integration | API integration with EHR/RCM | API and CRM/case management integration | EHR integration; adapts to existing workflows |
| Time to value | FastTrack copilot starts without integration; full API weeks | Relatively fast | Custom build (weeks to months) | Day 1 value |
Pricing (Inferred)
| Vendor | Pricing Model | Notes |
|---|---|---|
| Infinitus | Per-call / per-task, enterprise contracts | 400% ROI framing ($5M return per $1M invested) |
| SuperDial | Per-call pricing | 50% cost savings vs manual calls documented |
| Neon Health | Custom / outcome-based per workflow | 70% cost reduction per BV |
| Coral AI | Per-workflow or subscription | Growth metrics suggest volume-based pricing |
Use Case Recommendations
When to choose Infinitus
Default choice for mid-to-large pharma manufacturers and hub services organizations needing high-volume payer call automation at proven enterprise scale. 8 of top 10 pharma as customers, knowledge graph from 4M+ calls, 1,400+ payers, 1,000+ therapies, and $102.9M from top-tier VCs make it the most battle-tested option.
Best for:
- Hub services operations managing BV and PA follow-up calls for specialty medications
- Proven performance at scale across hundreds of payers
- Post-submission PA follow-up tracking automation
- FastTrack copilot mode for IVR bypass without full integration
- Maximum compliance/hallucination control requirements
Weakness: Not a pre-submission or PA initiation tool. Voice-first — lacks portal automation or multi-channel orchestration.
When to choose Neon Health
Strongest choice for hub services organizations wanting end-to-end workflow automation across the full specialty Rx journey. The CareMetx case study (300% ROI, doubled BV throughput, 70% cost reduction) with a top hub platform COO as public reference is a meaningful data point.
Best for:
- Hub programs with high BV and PA call volume
- Extending beyond payer calls to patient onboarding, copay enrollment, adherence
- Multi-channel hubs (portal, phone, fax, SMS) wanting single automation layer
- Custom workflow requirements
Weakness: Seed stage with six pharma brand customers and $6M raised. Custom-build model means slower time to value versus Infinitus.
When to choose SuperDial
Not purpose-built for pharma manufacturer or hub services workflows. Customers are RCM companies, DSOs, and provider billing teams. Not the right fit for pharma commercial operations evaluating AI PA for hub or PSP.
Relevant for: specialty pharmacies, infusion centers, or physician practices managing PA calls in-house. Could be a tool for a specialty pharmacy in a manufacturer’s preferred network.
When to choose Coral AI
Not a PA automation vendor in the pharma hub services sense. Value is in pre-submission: reading messy referral packets, extracting data, checking eligibility, drafting PA requests. Customers are DME providers, infusion centers, specialty clinics.
Relevant to pharma if: building or operating a hub that handles inbound referral documents from providers. Could layer in before handing off to a voice AI tool like Infinitus or Neon Health.
Verdict
Vendor Strength/Weakness Summary
| Vendor | Strongest At | Weakest At |
|---|---|---|
| Infinitus | Payer call automation at scale; pharma/hub use cases; compliance; breadth (1,400+ payers, 1,000+ therapies) | Pre-submission PA prep; multi-channel orchestration beyond voice |
| SuperDial | Provider-side RCM call automation; cost-per-call economics | Pharma/hub services fit; specialty therapy knowledge |
| Neon Health | End-to-end patient access workflows; hub services fit; multi-channel; CareMetx reference | Early stage; limited scale data; custom-build model slows deployment |
| Coral AI | Pre-submission document intake and PA preparation; unstructured document handling | Payer call automation; pharma/hub fit; specialty therapy depth |
Overall Recommendation for Pharma Commercial Operations
Go with Infinitus if you need proven enterprise-scale payer call automation today. The track record across 8 of the top 10 pharma companies, payer and therapy knowledge depth, and compliance architecture maturity are unmatched. The 400% ROI and Cencora metrics are the most independently credible in this group.
Shortlist Neon Health as a strategic alternative or complement — particularly for end-to-end hub workflow automation beyond payer calls. The CareMetx partnership signals strong product-market fit. Accept early-customer risk and negotiate accordingly.
Avoid SuperDial and Coral AI for pharma hub services PA workflows — not because they are weak products, but because they are built for different buyers. Both could become relevant as point solutions (Coral for document intake; SuperDial for SP-side RCM).
The competitive picture will shift as Neon Health scales. If it raises a meaningful Series A, it will be a genuine challenger to Infinitus for new hub program mandates.
Related Wiki Pages
Vendor Profiles
- Infinitus Systems
- SuperDial
- Neon Health
- Coral AI
- CareMetx — Neon Health design partner/reference customer
Category Pages
Concept Pages
- Prior Authorization
- Hub Services Overview
- Patient Access Journey
Related Comparisons
Frequently Asked Questions
What are the best AI prior authorization tools for pharma?
For pharma manufacturers and hub services, Infinitus Systems is the proven leader with 8 of the top 10 pharma companies as customers, $102.9M in funding, and a knowledge graph from 4M+ payer calls across 1,400+ payers and 1,000+ therapies. Neon Health is the strongest emerging alternative for end-to-end hub workflow automation, with a CareMetx design partnership demonstrating 300% ROI and 70% cost reduction per benefit verification. SuperDial and Coral AI serve provider-side and RCM use cases rather than pharma hub services.
How much can AI reduce prior authorization costs?
AI PA automation delivers significant cost savings across the workflow. Infinitus reports 400% ROI ($5M return per $1M invested) and 30% faster calls with 10% higher quality than human agents. Neon Health's CareMetx case study shows 300% ROI within three months, doubled BV throughput, and 70% reduction in per-BV labor cost. SuperDial documents 3x cost savings per call and 4x productivity gains on the provider side. Total drug PA costs are estimated at $93.3 billion per year across the system, creating massive savings potential.
What is the CMS prior authorization rule and how does it affect pharma?
The CMS Interoperability and Prior Authorization Final Rule sets 2026 compliance deadlines mandating electronic PA APIs with 72-hour urgent and 7-day standard turnaround times. This regulatory tailwind is accelerating adoption of AI PA tools, with AI PA spending growing roughly 10x year-over-year from approximately $10M in 2024 to $100M in 2025. The global AI-powered PA market is projected to reach $7.12 billion by 2033 at an 18.7% CAGR.
Should pharma companies use Infinitus or Neon Health for AI prior authorization?
Infinitus is the safer choice for enterprises needing proven, high-scale payer call automation today, with 6 years in market, HITRUST certification, and deep payer coverage. Neon Health is the stronger choice for hub organizations wanting end-to-end workflow automation beyond just payer calls, covering BV through PA through financial assistance across voice, portal, fax, and SMS channels. Many programs may benefit from both: Neon Health for multi-channel orchestration and Infinitus for high-volume voice automation at scale.